Prevention and Treament of Botulism
Abstract
Abstract Concerns regarding botulinum neurotoxins (BoNTs) as biowarfare and bioterrorist agents have generated interest in developing medical countermeasures for protection against the neurotoxins. Efforts have focused on improvements in the available vaccines and antisera and de novo discovery of pharmacological inhibitors of toxin action. This chapter reviews the various approaches taken to develop next-generation vaccines, antitoxins and pharmacological treatments against intoxication by the BoNTs. The historical progression, current status and future trends are described.
Document Details
- Document Type
- Technical Report
- Publication Date
- Jan 01, 2014
- Accession Number
- ADA607344
Entities
People
- Brian Molles
- Edward Eitzen
- George Oyler
- Michael Adler
- Nizamettin Gul
Organizations
- United States Army Medical Research Institute of Chemical Defense